STAT3 and cancer: The potency of MH in inhibiting this critical signaling pathway in cancer cells was demonstrated by the fact that as low as 0.03% solution (w/v) of MH (equivalent to a concentration of 0.3mg/mL) was sufficient to cause a significant reduction in p-STAT3 levels [23].